These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7722008)

  • 21. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A commercial vaccine for ovine toxoplasmosis.
    Buxton D; Innes EA
    Parasitology; 1995; 110 Suppl():S11-6. PubMed ID: 7784124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological diagnosis of toxoplasmosis in sheep following vaccination and challenge.
    Maley SW; Thomson KM; Bos HJ; Buxton D
    Vet Rec; 1997 May; 140(21):558-9. PubMed ID: 9185313
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Toxoplasma gondii and Neospora caninum infections in sheep from Uberlândia, Minas Gerais State, Brazil, by different serological methods.
    Rossi GF; Cabral DD; Ribeiro DP; Pajuaba AC; Corrêa RR; Moreira RQ; Mineo TW; Mineo JR; Silva DA
    Vet Parasitol; 2011 Feb; 175(3-4):252-9. PubMed ID: 21075529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxoplasma gondii infection in sheep and cattle.
    Esteban-Redondo I; Innes EA
    Comp Immunol Microbiol Infect Dis; 1997 Feb; 20(2):191-6. PubMed ID: 9208205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii.
    Dubey JP; Baker DG; Davis SW; Urban JF; Shen SK
    Am J Vet Res; 1994 Jul; 55(7):982-7. PubMed ID: 7978639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal mixture of Toxoplasma gondii recombinant antigens (GRA1, P22, ROP1) for diagnosis of ovine toxoplasmosis.
    Holec-Gąsior L; Ferra B; Hiszczyńska-Sawicka E; Kur J
    Vet Parasitol; 2014 Dec; 206(3-4):146-52. PubMed ID: 25300561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma expression and infectivity of Toxoplasma infected tissues in experimentally infected sheep in comparison with pigs.
    Verhelst D; De Craeye S; Jennes M; Dorny P; Goddeeris B; Cox E
    Vet Parasitol; 2015 Jan; 207(1-2):7-16. PubMed ID: 25499128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of kinetics and single-read enzyme-linked immunoassays for detection of Toxoplasma gondii antibodies in sheep.
    Werre SR; Jacobson RH; Bowman DD; Dubey JP; Mohammed HO
    J Vet Diagn Invest; 2002 May; 14(3):225-30. PubMed ID: 12033678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.
    Lu G; Zhou A; Meng M; Wang L; Han Y; Guo J; Zhou H; Cong H; Zhao Q; Zhu XQ; He S
    BMC Infect Dis; 2014 Dec; 14():3862. PubMed ID: 25527277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis.
    Roque-Reséndiz JL; Rosales R; Herion P
    Parasitology; 2004 Apr; 128(Pt 4):397-405. PubMed ID: 15151145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in developing vaccines against Toxoplasma gondii: an update.
    Zhang NZ; Wang M; Xu Y; Petersen E; Zhu XQ
    Expert Rev Vaccines; 2015; 14(12):1609-21. PubMed ID: 26467840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of anti-Toxoplasma gondii antibodies in Egyptian sheep and goats.
    Al-Kappany YM; Abbas IE; Devleesschauwer B; Dorny P; Jennes M; Cox E
    BMC Vet Res; 2018 Apr; 14(1):120. PubMed ID: 29606142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.
    Kringel H; Dubey JP; Beshah E; Hecker R; Urban JF
    Vet Parasitol; 2004 Aug; 123(1-2):55-66. PubMed ID: 15265571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
    Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
    J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.
    Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X
    Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasma gondii: its effect on the ovine popliteal lymph node.
    Buxton D; Miller HR; Finlayson J; Wallace GR
    J Med Microbiol; 1981 Nov; 14(4):435-42. PubMed ID: 7310845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.